Role of human factor VIII in factor X activation.
Author:
- M B HultinMHM B Hultin
Open Access
- 1 April 1982
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 69 (4) , 950-958
Abstract
The cofactor function of human Factor VIII in Factor X activation was investigated by an initial-rate assay of 3H-Factor X activation in the presence of human factor IXa, Ca2+, and either phospholipid or fresh washed human platelets. Purified Factor VIII that has not been activated by thrombin or Factor Xa supports Factor X activation after a lag of several minutes. A specific inhibitor of Factor Xa, which had no inhibitory activity against Factor IXa, markedly prolonged this lag, whereas specific thrombin inhibitors did not prolong the lag. These data support the conclusion that unactivated Factor VIII has no ability to support Factor X activation in a purified system until it is activated by Factor Xa feedback during the lag period. When Factor VIII was optimally preactivated by thrombin, the lag was completely abolished, regardless of the order of addition of the other reactants or the phospholipid source. These data indicate that there is no slow, time-dependent ordering of the reactants at the phospholipid or activated platelet surface if Factor VIII has been preactivated. Unactivated platelets did not support Factor X activation by Factors IXa and VIII. The effect of activated Factor VIII on the kinetics of bovine Factor X activation was primarily to increase the Vmax (54-fold), whereas with human Factor X, Factor VIII both increased the Vmax 56-fold and decreased the Km sixfold to 0.14 microM, similar to the plasma concentration of Factor X. Therefore, a change in the plasma factor X concentration would be expected to have a major effect on the rate of Factor X activation in vivo.Keywords
This publication has 26 references indexed in Scilit:
- Preparation and properties of bovine factor VIII (antihemophilic factor)Biochemistry, 1980
- The inhibition of the intrinsic generation of activated factor X by heparin and hirudinThrombosis Research, 1980
- Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amideBiochemistry, 1979
- The role of factors VIII and IX in the activation of bovine blood coagulation factor XThrombosis Research, 1979
- Activation of human factor IX (Christmas factor).Journal of Clinical Investigation, 1978
- Proteolytic activation of protein C from bovine plasmaBiochemistry, 1976
- Mechanism of activation of bovine factor X (Stuart factor) by intrinsic and extrinsic pathwaysBiochemistry, 1974
- Formation of Intrinsic Factor‐X‐Activator Activity, with Special Reference to the Role of ThrombinBritish Journal of Haematology, 1971
- Synthesis of intrinsic factor X activator. Inhibition of the function of formed activator by antibodies to factor VIII and to factor IXBiochemistry, 1970
- The role of heparin in intrinsic blood coagulationJournal of Biomedical Materials Research, 1969